FDA-cleared AI tools now decode triple-negative breast cancer biomarkers in imaging scans, enabling earlier diagnosis and personalized therapies while raising ethical questions about algorithmic trans...
HTRecNet’s AI achieves 94% accuracy in detecting liver cancers, reduces diagnostic delays by 3 weeks, and cuts unnecessary biopsies by 40% according to recent clinical trials. A new AI system re...
A JAMA Oncology study reveals AI detects 65.8% of breast cancer recurrences post-mastectomy versus radiologists’ 55%, but its lower specificity underscores the need for collaborative human-AI diagno...